Comparing Fluoroscopy and Technological Methods for Guidance During Endovascular Procedures
Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Jul 24, 2006
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • AAA with diameter \> 5,0 cm suitable for endovascular technique
- • Normal creatinine
- • \> 60 years of age
- Exclusion Criteria:
- • Known heart failure or unstable coronary disease
- • Other morbidity than normally contraindicates endovascular treatment
About Norwegian University Of Science And Technology
The Norwegian University of Science and Technology (NTNU) is a leading research institution dedicated to advancing knowledge and innovation in various scientific fields. Renowned for its commitment to interdisciplinary collaboration, NTNU plays a pivotal role in addressing global health challenges through rigorous clinical trials and research initiatives. The university's emphasis on cutting-edge technology and its strong partnerships with healthcare sectors position it as a key player in translational research, ensuring that findings contribute effectively to improving public health and patient care. With a focus on ethical standards and scientific integrity, NTNU is dedicated to fostering advancements that enhance the quality of life and health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trondheim, , Norway
Patients applied
Trial Officials
Frode Manstad-Hulaas, MD
Principal Investigator
Norwegian University of Science and Technology
Petter Aadahl, Professor
Study Director
Norwegian University of Science and Technology
Toril N Hernes, Professor
Study Director
SINTEF Health Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials